BDBM260965 US9540323, 162::US9540323, example 162
SMILES: CC1(C)CN(c2c1c(c(F)cc2O)-c1ccc(Cl)cn1)c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1
InChI Key: InChIKey=CDSXTTYOKDIPKK-UHFFFAOYSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Purinergic receptor P2Y1 (Homo sapiens (Human)) | BDBM260965 (US9540323, 162 | US9540323, example 162) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 6.40 | -11.2 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description A SPA membrane binding assay was used to identify inhibitors of [33P] 2MeS-ADP binding to cloned human P2Y1 receptors (The P2Y1 receptor membranes we... | US Patent US9540323 (2017) BindingDB Entry DOI: 10.7270/Q289141P | |||||||||||
More data for this Ligand-Target Pair |